The intensity of radiotherapy-elicited immune response is associated with esophageal cancer clearance. (Q33746544)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

title

The intensity of radiotherapy-elicited immune response is associated with esophageal cancer clearance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Jin-lu Ma

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Long Jin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Yao-Dong Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Chen-chen He

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Xi-jing Guo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Rui Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Yun-Yi Yang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

language of work or name

1 reference

22 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

Journal of Immunology Research

21 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

volume

2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

page(s)

794249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

21 March 2020

copyright license

start time

1 January 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Chromatin structure and radiation-induced DNA damage: from structural biology to radiobiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

Targeting gamma delta T cells for cancer immunotherapy: bench to bedside

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

Advances and future of Radiation Oncology

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

Interleukin-6 signaling drives fibrosis in unresolved inflammation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

The impact of radiation therapy on the antitumor immunity: local effects and systemic consequences

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

New insights into the role of the immune microenvironment in breast carcinoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

Cell-mediated autophagy promotes cancer cell survival.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

Comparison of the cytotoxic response against ovarian cancer by immune effector cells isolated and expanded from normal donors and ovarian cancer patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

Radiotherapy in elderly patients with inoperable esophageal cancer. Is there a benefit?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

Interleukin 2-activated killer cells: generation in collaboration with interferon gamma and its suppression in cancer patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

Clinicopathologic and prognostic factors of young and elderly patients with esophageal adenocarcinoma: is there really a difference?

21 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F794249

Immune response evaluation through determination of type 1, type 2, and type 17 patterns in patients with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F794249

The association of CXCR3 and renal cell carcinoma metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F794249

A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F794249

Evaluation of response to neoadjuvant chemotherapy for esophageal cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F794249

Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4055126

Longitudinal Cytokine Expression during IMRT for Prostate Cancer and Acute Treatment Toxicity

30 October 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F794249

SJSZ glycoprotein (38kDa) prevents thymus atrophy and enhances expression of IL-2 and IL-12 in diethylnitrosamine-induced hepatocarcinogenesis

21 January 2018

1 reference

12 December 2020

Establishment of an X-ray irradiation-induced glossitis model in rats: biphasic elevation of proinflammatory cytokines and chemokines

1 reference

12 December 2020

Cancer therapeutics: Targeting the apoptotic pathway

1 reference

12 December 2020

Changes in immunological parameters during interleukin 2 and interferon 2 alpha treatment of recurrent renal cell carcinoma and malignant melanoma

1 reference

12 December 2020

Identifiers

DOI

10.1155/2014/794249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

PubMed publication ID

24967419

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24967419%20AND%20SRC:MED&resulttype=core&format=json